What is confidential? – The FAQ Edition
Our recent post entitled “What is confidential?” triggered a few questions and comments via email. Our latest post tackles these questions.
Menu
What is confidential?
What is confidential? And what should you disclose before and after a CDA is signed?
Have We Forgotten About Japan?
Is Japan being ignored as a licensing partner in the biotech industry? Is China now getting all of the attention? Lacerta Bio explores this question.
Can AI Revolutionize Business Development?
Want to spend an entire decade surfing the web? Try finding and reading every article on “artificial intelligence.” A serious branch of computer science has rapidly turned into a buzzword…
#BIOEuropeSpring: Muscles, Meetings, and Mustard
Last week was another jam-packed week of meetings, this time at BIO-Europe Spring in Amsterdam. It is only our third appearance at this event, having participated in previous BIO…
Out-Licensing: How hard is it, really?
Is out-licensing difficult? Yes, of course it is. But how difficult is it? Is this something which can be quantified? And, why would we want to quantify this anyway? These…
LIME: The Secret to Better Out-Licensing?
The humble lime...sour, sweet, juicy, and an essential ingredient in many desserts and beverages. Lime also (supposedly) has many health benefits, including weight loss, improved digestion, and improved skin. But…
Thoughts Leading Up To #BIO2017
#BIO2017 is days away. What can we expect? Crowded Partnering - By our unofficial count, the number of companies registered for One-on-One Partnering exceeds the number from San…
When Does BIO Start?
BIO starts in June, right? Wrong. Perhaps BIO starts in late April, when partnering opens? Sorry. Wrong again. BIO started the moment you decided to…
Is My Asset Licensable?
This is a good question...a question which lacks a simple answer without quite a bit of analysis. We audit out-licensing processes, and there are times when the answer is…